Month: March 2024

AS Harju Elekter Group presents its consolidated audited Annual Report for 2023 prepared by the Management Board and approved by the Supervisory Board. Compared to the unaudited interim report published on 21 February 2024, there are no differences in the audited financial results. The consolidated audited revenue for the year 2023 was 209.0 million euros, the operating profit was 8.1 million euros and net profit 5.2 million euros. The original audited Annual Report 2023 document is submitted in machine-readable .xhtml format to the Nasdaq Tallinn Stock Exchange and digitally signed (link: https://nasdaqbaltic.com/statistics/en/instrument/EE3100004250/reports). Tiit Atso Chairman of the Management Board +372 674 7400AttachmentsAnnual Report of Harju Elekter 2023Harju Elekter Group aastaaruanne 2023 EST...

LONDON, March 27, 2024 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), and Vayana TradeXchange announce a partnership to use Arqit’s TradeSecure™ digital negotiable instrument technology to transform international supply chains. Vayana TradeXchange is a global marketplace facilitating the financing of cross-border trade, headquartered in GIFT City and operating under license from the International Financial Services Authority in India (IFSCA). It is part of the Vayana Group which operates India’s largest regulated network for domestic supply chain finance. The initial focus for the partnership will be India, Singapore, the United Arab Emirates (UAE) and the United Kingdom (UK), nations that are global leaders in the digitalisation of trade. These countries have embraced legislation based on the UN’s...

ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) — Cardlytics, Inc. (NASDAQ: CDLX) (“Cardlytics”), an advertising platform in banks’ digital channels, today announced the pricing of its offering of $150.0 million aggregate principal amount of 4.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes are scheduled to settle on April 1, 2024, subject to customary closing conditions. Cardlytics also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $22.5 million aggregate principal amount of notes. The notes will be senior, unsecured...

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) — PROBE GOLD INC. (TSX-V: PRB) (OTCQB: PROBF) (“Probe” or the “Company”) is pleased to announce the filing of the independent Preliminary Economic Assessment (“PEA”) technical report  which has been prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects, on its 100% owned Novador Project, located in Val-d’Or, Québec. The Novador PEA supports a robust mining plan that averages over 255,000 ounces per year of gold production, with over 281,000 ounces per year in the first five years of the 12.6-year mine life and boasts an impressive after-tax NPV of $910 million using a base-case gold price of US$1,750/oz. The technical report, entitled “Novador Project, NI 43-101 Technical Report & Preliminary Economic Assessment” (the “Novador...

For a limited time, get a Galaxy S23 with Galaxy AI on us with a new line on Verizon myPlan¹ NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) — Verizon customers will soon be able to experience Samsung One UI 6.1 with Galaxy AI2 on additional Samsung smartphones beyond the Galaxy S24 series. This expansion includes popular models, such as the Galaxy S23 series, Galaxy S23 FE, Galaxy Z Fold5 and Galaxy Z Flip5. With this update, you can unlock a host of innovative features to enhance your life, work and mobile experience. Verizon Galaxy S23 Offer: Check everything Galaxy AI has to offer with this amazing deal. For a limited time, get a new Galaxy S23 on us when you purchase your new phone with a new line on myPlan – no trade-in required1. Whether you’re upgrading to the Galaxy S23 series, Galaxy S23 FE, Galaxy Z Fold5 and Galaxy Z Flip5,...

LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-166 (ibudilast) for the treatment of macular injury associated with progressive multiple sclerosis. Once issued, this patent is expected to expire no earlier than October 2039.  The allowed claims cover the use of MN-166 (ibudilast) for treating macular injury associated with progressive multiple sclerosis and for decreasing macular volume loss associated with progressive multiple sclerosis. The allowed claims specifically cover both primary progressive multiple sclerosis and secondary...